Home Blood Transfusions

Abroad (travel likely)Recruiting

Conditions

Hematologic Malignancy · Myelodysplastic Syndromes · Acute Myeloid Leukemia · Transfusion Dependent Cytopenias

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Adam Binder, MD) · adam.binder@jefferson.edu · 215-955-8874

Study leads

Adam Binder, MD
Principal Investigator
Adam.Binder@jefferson.edu

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Myelodysplastic Syndrome

Abroad (travel likely)RecruitingPHASE1

Duarte, United States

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Tucson, United States · Tucson, United States

IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

Acute Myeloid Leukemia · Relapse/Recurrence

Abroad (travel likely)RecruitingPHASE3

Brno, Czechia · Hradec Králové, Czechia

PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia

Acute Myeloid Leukemia · Acute Promyelocytic Leukemia With PML-RARA

Abroad (travel likely)RecruitingPHASE1

Houston, United States